CynthiaLevyMD
Gastroenterology • Miami, FLHepatology & Liver Transplantation
Associate Professor, Medicine, University of Miami School of Medicine
Dr. Levy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 NW 12th Ave
Miami, FL 33136Phone+1 305-243-5757Fax+1 305-243-3762
Summary
- Dr. Cynthia Levy is a gastroenterologist in Miami, FL and is affiliated with multiple hospitals in the area, including Jackson Health System, University of Miami Hospital, and University of Miami Hospital and Clinics. She received her medical degree from Faculdade de Medicina da Universidade Federal do Rio de Janeiro and has been in practice 22 years. She specializes in hepatology & liver transplantation and is experienced in general gastroenterology and hepatology.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2001 - 2004
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1998 - 2001
Faculdade de Medicina da Universidade Federal do Rio de JaneiroClass of 1995
Certifications & Licensure
FL State Medical License 2002 - 2026
MN State Medical License 2001 - 2004- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Use of Fenofibrate for Primary Biliary Cirrhosis Start of enrollment: 2007 Aug 01
- Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis Start of enrollment: 2011 Apr 01
- Pilot Study of Fenofibrate for PSC Start of enrollment: 2010 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 203 citationsInternational genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathwaysHeather J. Cordell, Younghun Han, George F. Mells, Yafang Li, Gideon M. Hirschfield
Nature Communications. 2015-09-22 - 84 citationsA randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA.Jörn M. Schattenberg, Albert Parés, Kris V. Kowdley, Michael A. Heneghan, Stephen H. Caldwell
Journal of Hepatology. 2021-01-21 - 428 citationsPrimary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases.Keith D. Lindor, Christopher L. Bowlus, James L. Boyer, Cynthia Levy, Marlyn J. Mayo
Hepatology. 2018-01-01
Press Mentions
VCU Liver Specialist Partners with Patient Group to Study Rare Disease’s ImpactOctober 22nd, 2024- Real-World Data Finds High Prevalence of Pruritis (Itching) and Fatigue, Low Levels of Treatment in Primary Biliary Cholangitis PopulationJuly 20th, 2022
- CymaBay Therapeutics to Host Post-AASLD Key Opinion Leader Webinar on Seladelpar for Primary Biliary CholangitisNovember 11th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
